These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7735688)

  • 1. Structural requirements at the melatonin receptor.
    Sugden D; Chong NW; Lewis DF
    Br J Pharmacol; 1995 Feb; 114(3):618-23. PubMed ID: 7735688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogues of diverse structure are unable to differentiate native melatonin receptors in the chicken retina, sheep pars tuberalis and Xenopus melanophores.
    Pickering H; Sword S; Vonhoff S; Jones R; Sugden D
    Br J Pharmacol; 1996 Sep; 119(2):379-87. PubMed ID: 8886424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the chicken brain melatonin-binding protein using iodinated and tritiated ligands.
    Kennaway DJ; Hugel HM; Rowe SA
    J Pineal Res; 1994 Oct; 17(3):137-48. PubMed ID: 7897586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sedative potency and 2-[125I]iodomelatonin binding affinity of melatonin analogues.
    Sugden D
    Psychopharmacology (Berl); 1995 Feb; 117(3):364-70. PubMed ID: 7770612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-bromoacetyl 5-methoxytryptamine: an irreversible melatonin ligand?
    Chong NW; Evans JE; Sugden D
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1355-61. PubMed ID: 8391805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-[125I]iodo-5-methoxycarbonylamino-N-acetyltryptamine: a selective radioligand for the characterization of melatonin ML2 binding sites.
    Molinari EJ; North PC; Dubocovich ML
    Eur J Pharmacol; 1996 Apr; 301(1-3):159-68. PubMed ID: 8773460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
    Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
    J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermodynamic analysis of agonist and antagonist binding to the chicken brain melatonin receptor.
    Chong NW; Sugden D
    Br J Pharmacol; 1994 Jan; 111(1):295-301. PubMed ID: 8012710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-[125I]iodomelatonin binding sites in hamster brain membranes: pharmacological characteristics and regional distribution.
    Duncan MJ; Takahashi JS; Dubocovich ML
    Endocrinology; 1988 May; 122(5):1825-33. PubMed ID: 2834175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibitory effects of melatonin analogs and three naphthalenic ligands on 2-[125I]iodomelatonin binding to chicken tissues.
    Pang CS; Tang PL; Song Y; Pang SF; Ng KW; Guardiola-Lemaitre B; Delagrange P; Brown GM
    J Pineal Res; 1997 Oct; 23(3):148-55. PubMed ID: 9406986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 2-[125I]iodomelatonin to characterize melatonin binding sites in chicken retina.
    Dubocovich ML; Takahashi JS
    Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3916-20. PubMed ID: 3035559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioligand binding affinity and biological activity of the enantiomers of a chiral melatonin analogue.
    Sugden D; Davies DJ; Garratt PJ; Jones R; Vonhoff S
    Eur J Pharmacol; 1995 Dec; 287(3):239-43. PubMed ID: 8991796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
    Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
    J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.
    Teh MT; Sugden D
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonergic properties of the (+)- and (-)-enantiomers of N-(4-methoxy-2,3-dihydro-1H-phenalen-2-yl)amide derivatives.
    Jellimann C; Mathé-Allainmat M; Andrieux J; Renard P; Delagrange P; Langlois M
    J Med Chem; 1999 Mar; 42(6):1100-5. PubMed ID: 10090792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the melatonin receptor. 3. Design and synthesis of melatonin agonists and antagonists derived from 2-phenyltryptamines.
    Garratt PJ; Jones R; Tocher DA; Sugden D
    J Med Chem; 1995 Mar; 38(7):1132-9. PubMed ID: 7707316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin receptor pharmacology: toward subtype specificity.
    Sugden D; Pickering H; Teh MT; Garratt PJ
    Biol Cell; 1997 Nov; 89(8):531-7. PubMed ID: 9618903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin receptors on human granulosa cell membranes.
    Yie SM; Niles LP; Younglai EV
    J Clin Endocrinol Metab; 1995 May; 80(5):1747-9. PubMed ID: 7745030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding affinity and biological activity of oxygen and sulfur isosteres at melatonin receptors as a function of their hydrogen bonding capability.
    Davies DJ; Faust R; Garratt PJ; Marivingt-Mounir C; Kathryn Davidson ; Teh MT; Sugden D
    Bioorg Chem; 2004 Feb; 32(1):1-12. PubMed ID: 14700558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of melatonin receptors in the brain of four avian species: duck, goose, pigeon, and turkey.
    Zawilska JB; Nowak JZ
    Gen Comp Endocrinol; 1996 Feb; 101(2):227-34. PubMed ID: 8812381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.